Antibiotic Selection for Acute Respiratory Infection

Introduction to Antibiotic Selection

• The Infectious Diseases Society of America recommends amoxicillin-clavulanate as the preferred first-line agent for acute bacterial sinusitis based on concern for ampicillin-resistant Haemophilus influenzae and Moraxella catarrhalis 1

Clinical Assessment and Diagnosis

• Persistent symptoms ≥10 days without improvement suggests bacterial sinusitis 2, 1
• Severe symptoms (fever >39°C with purulent nasal discharge or facial pain) for ≥3 consecutive days 2, 1
• "Double sickening" - worsening after initial improvement from a viral upper respiratory infection 2, 1

Antibiotic Efficacy and Resistance

• The predicted clinical efficacy of amoxicillin-clavulanate is 90-92% against major respiratory pathogens including Streptococcus pneumoniae, H. influenzae, and M. catarrhalis 1
• Azithromycin is explicitly contraindicated due to resistance rates exceeding 20-25% for both S. pneumoniae and H. influenzae 1

Adjunctive Therapies

• Intranasal corticosteroids (mometasone, fluticasone, or budesonide twice daily) reduce mucosal inflammation and improve symptom resolution 2, 1
• Saline nasal irrigation provides symptomatic relief 2, 1
• Analgesics (acetaminophen or ibuprofen) for pain and fever 2, 1

Treatment Monitoring and Follow-Up

• Reassess at 3-5 days: If no improvement, switch to high-dose amoxicillin-clavulanate (2 g twice daily) or respiratory fluoroquinolone 1
• Reassess at 7 days: If symptoms persist or worsen, reconfirm diagnosis and consider complications 1
• Expected improvement timeline: Most patients show noticeable improvement within 3-5 days, with complete resolution by 10-14 days 1